Arkolith/Insider Trading/RPHM/Form 4

Novo Holdings A/S

10% OwnerReneo Pharmaceuticals, Inc. (RPHM) · full profile →Form 4 · filed Apr 14, 2021
Net Buying
Open-Market Buys
$10.0M
Open-Market Sells
$0
Net Open-Market Flow
$10.0M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 13, 2021Buy(P)667K$15.00$10.0M3.4M
Apr 13, 2021Conversion(C)2.8M——2.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 13, 2021Conversion(C)12.4M——0

Transaction Codes

P
Open-market purchase
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-026667) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML